| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Glycyrrhizic Acid | Diabetes | 1 | PM | 32981927 | 📋 | Ability of Post-treatment Glycyrrhizic Acid to Mitigate Cerebral Ischemia/Reperfusion Injury in Diabetic Mice |
| Glycyrrhizic Acid | Diabetes Type 1 | 1 | PM | 35031620 | 📋 | Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes |
| Glycyrrhizic Acid | Diabetic Cardiomyopathy | 1 | PM | 34512937 | 📋 | Cardioprotective Action of Glycyrrhizin on Diabetic Rats with Myocardial Remodeling |
| Glycyrrhizic Acid | Diabetic Cardiomyopathy | 2 | PM | 33924458 | 📋 | Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats |
| Glycyrrhizic Acid | Diabetic Complications | 1 | PM | 33347772 | 📋 | Effects of Glycyrrhizin Treatment on Diabetic Cornea |
| Glycyrrhizic Acid | Diabetic Nephropathy | 1 | PM | 37450070 | 📋 | Glycyrrhizic Acid Protects Glomerular Podocytes Induced by High Glucose by Modulating SNARK/AMPK Signaling Pathway |
| Glycyrrhizic Acid | Diabetic Neuropathy | 2 | PM | 35578754 | 📋 | Glycyrrhizic acid promotes sciatic nerves recovery in type 1 diabetic rats and protects Schwann cells from high glucose-induced cytotoxicity |
| Glycyrrhizic Acid | Diabetic Neuropathy | 1 | PM | 34073550 | 📋 | Ammonium Glycyrrhizinate Prevents Apoptosis and Mitochondrial Dysfunction Induced by High Glucose in SH-SY5Y Cell Line and Counteracts Neuropathic Pain in Streptozotocin-Induced Diabetic Mice |
| Glycyrrhizic Acid | Diabetic Ulcers and Sores | 1 | PM | 36678656 | 📋 | Glycyrrhizin-Based Hydrogels Accelerate Wound Healing of Normoglycemic and Diabetic Mouse Skin |
| Glycyrrhizic Acid | Diabetic Vasculopathy | 2 | PM | 35987259 | 📋 | Glycyrrhizin ameliorates vascular endothelial cell senescence by inhibiting HMGB1 in HFD/STZ-induced diabetic rats and human umbilical vein endothelial cells |
| Glycyrrhizic Acid | Diabetic Vasculopathy | 1 | PM | 23528363 | 📋 | Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-κB pathway activation in human umbilical vein endothelial cells |
